Yongde Liao

2.2k total citations
75 papers, 1.1k citations indexed

About

Yongde Liao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Yongde Liao has authored 75 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 25 papers in Cancer Research. Recurrent topics in Yongde Liao's work include Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (14 papers) and Cytokine Signaling Pathways and Interactions (12 papers). Yongde Liao is often cited by papers focused on Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (14 papers) and Cytokine Signaling Pathways and Interactions (12 papers). Yongde Liao collaborates with scholars based in China, Netherlands and Taiwan. Yongde Liao's co-authors include Bo Ai, Changyu Liu, Quanfu Huang, Lutz Trojan, Peter Angel, Doris Mayer, Ulrich Abel, Zheng Zhang, Rainer Grobholz and Sheng Zhou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Free Radical Biology and Medicine.

In The Last Decade

Yongde Liao

71 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongde Liao China 18 453 425 317 281 170 75 1.1k
Paul Toren Canada 19 425 0.9× 681 1.6× 228 0.7× 272 1.0× 120 0.7× 77 1.2k
Takehiko Segawa Japan 18 600 1.3× 642 1.5× 190 0.6× 225 0.8× 184 1.1× 61 1.3k
Andreas Josefsson Sweden 18 340 0.8× 456 1.1× 257 0.8× 222 0.8× 58 0.3× 38 935
Kiyoshi Fujinami Japan 19 549 1.2× 442 1.0× 245 0.8× 208 0.7× 114 0.7× 45 1.2k
Elin Thysell Sweden 18 568 1.3× 415 1.0× 197 0.6× 359 1.3× 52 0.3× 38 1.1k
Yusuke Imamura Japan 15 315 0.7× 399 0.9× 154 0.5× 169 0.6× 70 0.4× 77 765
Mari Nakabayashi United States 22 453 1.0× 914 2.2× 292 0.9× 455 1.6× 165 1.0× 40 1.5k
Alison Reid United Kingdom 13 412 0.9× 746 1.8× 306 1.0× 400 1.4× 92 0.5× 20 1.1k
Natasja F. Dits Netherlands 16 575 1.3× 539 1.3× 158 0.5× 342 1.2× 143 0.8× 21 1.0k
Aijun Liu China 14 334 0.7× 507 1.2× 125 0.4× 167 0.6× 82 0.5× 66 956

Countries citing papers authored by Yongde Liao

Since Specialization
Citations

This map shows the geographic impact of Yongde Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongde Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongde Liao more than expected).

Fields of papers citing papers by Yongde Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongde Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongde Liao. The network helps show where Yongde Liao may publish in the future.

Co-authorship network of co-authors of Yongde Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Yongde Liao. A scholar is included among the top collaborators of Yongde Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongde Liao. Yongde Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Yongde, et al.. (2025). Estrogen, estrogen receptor and the tumor microenvironment of NSCLC. International Journal of Cancer. 156(8). 1501–1508. 3 indexed citations
2.
Li, Kuo, et al.. (2025). Multichannel deep learning prediction of major pathological response after neoadjuvant immunochemotherapy in lung cancer: a multicenter diagnostic study. International Journal of Surgery. 111(10). 6614–6626. 1 indexed citations
3.
Wang, Na, Xia Qin, Yongde Liao, et al.. (2024). Neoadjuvant chemoimmunotherapy achieved a pathologic complete response in stage IIIA lung adenocarcinoma harboring RET fusion: a case report. Frontiers in Immunology. 14. 1258762–1258762. 1 indexed citations
4.
Zheng, Yuting, Mingliang Wang, Hanting Li, et al.. (2024). CT-based delta-radiomics for predicting pathological response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a multicenter study. BMC Medical Imaging. 24(1). 329–329. 3 indexed citations
5.
Wang, Zhaokai, Quanchao Sun, Ai Huang, et al.. (2024). Efficacy, safety, and prognostic modeling in neoadjuvant immunotherapy for esophageal squamous cell carcinoma. International Immunopharmacology. 142(Pt A). 112845–112845. 3 indexed citations
6.
7.
Wang, Yangwei, et al.. (2023). ERβ promoted invadopodia formation‐mediated non‐small cell lung cancer metastasis via the ICAM1/p‐Src/p‐Cortactin signaling pathway. International Journal of Cancer. 153(6). 1287–1299. 5 indexed citations
9.
Chen, Jiaping, et al.. (2023). Stearoyl-CoA Desaturases1 Accelerates Non-Small Cell Lung Cancer Metastasis by Promoting Aromatase Expression to Improve Estrogen Synthesis. International Journal of Molecular Sciences. 24(7). 6826–6826. 8 indexed citations
10.
Han, Xiao, et al.. (2023). Critical Roles of METTL3 in Translation Regulation of Cancer. Biomolecules. 13(2). 243–243. 10 indexed citations
11.
Wang, Yangwei, et al.. (2023). A five-gene expression signature of centromeric proteins with prognostic value in lung adenocarcinoma. Translational Cancer Research. 12(2). 273–286. 3 indexed citations
13.
Li, Kuo, Chi Zhang, Hong Liu, et al.. (2023). Development and Validation of a Deep Learning Radiomics Model to Predict High-Risk Pathologic Pulmonary Nodules Using Preoperative Computed Tomography. Academic Radiology. 31(4). 1686–1697. 9 indexed citations
14.
Wang, Mingliang, et al.. (2022). Comparison of bronchial methylene blue staining and modified inflation-deflation method in identifying the intersegmental plane during lung segmentectomy. Translational Cancer Research. 11(11). 4000–4008. 1 indexed citations
15.
Fu, Shengling, Changyu Liu, Quanfu Huang, et al.. (2018). Estrogen receptor β1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer. Oncology Reports. 39(3). 1313–1321. 13 indexed citations
16.
Huang, Quanfu, Zheng Zhang, Yongde Liao, et al.. (2018). 17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression. Journal of Experimental & Clinical Cancer Research. 37(1). 133–133. 47 indexed citations
17.
Ai, Bo, Zheng Zhang, & Yongde Liao. (2014). Laparoscopic and thoracoscopic esophagectomy with intrathoracic anastomosis. ASVIDE. 1(1). 1 indexed citations
18.
Liu, Changyu, et al.. (2014). Crosstalk between IGF-1R and other Tumor Promoting Pathways. Current Pharmaceutical Design. 20(17). 2912–2921. 38 indexed citations
19.
Liao, Yongde. (2006). Expression and significance of IGF1,IGF1R and AKT,the components of IGF signaling pathway,in primary adenocarcinoma of the lung. 3 indexed citations
20.
Liao, Yongde. (2006). The Correlation between IGF1,IGF2 Expression and Lymph Node Metastasis in Non-small Cell Lung Cancer. Zhongliu fangzhi yanjiu. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026